<HashMap><database>iProX</database><scores/><additional><omics_type>Proteomics</omics_type><submitter>Shanling Xu</submitter><species>Mus Musculus</species><full_dataset_link>http://www.iprox.org/page/project.html?id=IPX0018735000</full_dataset_link><submitter_email>xushanling@scszlyy.org.cn</submitter_email><submitter_affiliation>Affiliated Cancer Hospital to University of Electronic Science and Technology of China</submitter_affiliation><sample_protocol></sample_protocol><repository>iProX</repository><data_protocol></data_protocol></additional><is_claimable>false</is_claimable><name>Mannose-Modified Lipid Nanoparticles Loaded with siZDHHC9 Remodel the Ras-ERK Signaling Axis in Antigen-Presenting Cells to Correct Th17/Treg Imbalance and Alleviate Fusobacterium nucleatum-Driven Ulcerative Colitis</name><description>Fusobacterium nucleatum-induced ulcerative colitis (UC) is characterized by persistent intestinal inflammation and an imbalance in immune homeostasis, in which abnormal activation of antigen-presenting cells (APCs) and a Th17/Treg imbalance play critical roles in disease progression. This study aimed to construct the mannose-modified lipid nanoparticles (LNPs) loaded with siZDHHC9 (Man-LNP@siZDHHC9). By integrating single-cell RNA sequencing (scRNA-seq) and multi-omics technologies, we systematically elucidated the molecular mechanisms by which Man-LNP@siZDHHC9 remodels APC-T cell interactions by inhibiting the HRas palmitoylation-mediated ERK signaling axis, thereby ameliorating Th17/Treg imbalance and alleviating Fusobacterium nucleatum-induced UC.</description><dates><publication>Fri Jul 31 00:00:00 GMT+01:00 2026</publication></dates><accession>PXD081963</accession><cross_references><TAXONOMY>10090</TAXONOMY></cross_references></HashMap>